According to survey data, the incidence of AF in China is basically close to 4% in Europe. The proportion is slightly lower than that of the United States. However, due to the large population base in China, it is estimated that there are approximately 8 to 11 million patients with AF in the country. However, contrary to the fact that foreign cardioverter defibrillators have become highly popular, the defibrillator market in our country has not really started yet. According to sales figures, it can be seen that the annual sales of various defibrillators in the international market amount to more than US$2 billion, while China’s sales are only RMB 100 million. The difference between the two shows that the gap is very large. In China's portable electronic medical product market, small-scale products such as blood pressure meters, blood glucose meters, and digital hearing aids, each with a price of several hundred yuan, are still the mainstream products, and defibrillators that are truly effective for the treatment of elderly patients. , Household suction machines, oxygen generators and other devices have not yet been popularized.

Cardiac defibrillators have become a popular medical device product in Western countries. Not only are hospitals and clinics of all sizes equipped, but even defibrillators are installed in conference rooms, theaters, cinemas, schools, hypermarkets, supermarkets, and public places. Patients with a history of atrial fibrillation are free of charge during sudden illnesses. use.

In the United States with high incidence of heart disease, according to statistics, about 35% to 40% of people with heart disease have portable defibrillators. In addition, about one to twenty medical device manufacturers in the United States are producing a variety of cardiac defibrillators, and the number of suppliers has reached more than 130. The price of various portable defibrillators developed and marketed in recent years is only From 1000 to 2,000 US dollars, this price has been reduced to the extent that most of its patients can tolerate. It can be seen that the defibrillator market in the United States is highly mature.

About one million patients each year in our country die of cardiac arrest, and a significant proportion of them are caused by atrial fibrillation. Since China has 8 million to 11 million heart patients, this is a huge market for defibrillator makers. So why has this market failed to start?

This is related to the fact that the defibrillator price in the domestic market is too expensive. In fact, China's defibrillator product market is still dominated by imported products. So far, foreign manufacturers have mastered the core technologies and thus controlled the pricing power of the defibrillator market in China.

As far as prices are concerned, the price of ordinary defibrillators on the market in China is usually between 30,000 and 60,000 yuan. The price of new portable defibrillators from Germany, the United States, and other manufacturers is usually 45,000 yuan, and the same products The local market sells for only 1800 to 2200 US dollars. The newly-listed two-way wave defibrillator and new defibrillator with a color heart rate monitor are priced at more than 100,000 yuan in China and only 10,000 US dollars in the United States. Imported medical device products in the domestic market to sell high prices or even high prices seem to have become the practice of some domestic foreign agent sales agents. Such a price, even if the product is no better, should not be said to be unbearable to the average working-class heart disease sufferer, and even basic-level medical institutions cannot afford it, let alone allow it to enter millions of households.

To completely solve this problem and promote the healthy development of China's defibrillator market, the government authorities must vigorously support the domestic defibrillator industry in terms of policies, such as tax incentives for domestic companies that have developed new defibrillator products. Only the government authorities can give policy support to enable domestic enterprises to produce defibrillator products with high quality and low price.